EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer (NYSE:PFE) Shares Climb 1.6% on Analyst Upgrade - Markets Daily
Pfizer (NYSE:PFE) Stock Jumps 1.6% Following Analyst Upgrade
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Pfizer (NYSE:PFE) Stock
Pfizer's Dividend Yield Is Above 6%. Wall Street May Be Sending a Warning - 24/7 Wall St.
Moderna stock jumps on planned national cancer vaccine effort
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Can Pfizer (PFE) Turn a Forward P/E Discount into Real Returns?
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
4 Household Name Stocks With Dividends in Danger
Florida AG sues Pfizer over COVID vaccine in St. Lucie County court
Pfizer Inc. $PFE Shares Sold by Sapient Capital LLC
150,553 Pfizer Inc. $PFE Shares Acquired by Farther Finance Advisors LLC
Explosion in tick diseases spurs race for treatment and prevention | News & Features | ArcaMax Publishing
From Baric's Blueprint to SV40 and Back Again
Artemis Investment Management LLP Sells 3,850,879 Shares of Pfizer Inc. $PFE - Zolmax
Pfizer Inc. $PFE Holdings Lifted by Quintet Private Bank Europe S.A.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Pfizer (PFE) Could Be 3% Below Fair Value After Fresh TUKYSA FDA Approval
Artemis Investment Management LLP Sells 3,850,879 Shares of Pfizer Inc. $PFE - Daily Political
Pfizer Is Just One Of These 3 AI Healthcare Stocks
Pfizer (PFE) Wins TUKYSA Approval And LITFULO Data, Is It Still 3% Undervalued?
FDA Approves Pfizer's TUKYSA Regimen For Front-Line HER2+ Breast Cancer Maintenance
Pfizer (NYSE:PFE) Given New $28.00 Price Target at Cantor Fitzgerald - Daily Political
Pfizer's TUKYSA Gets FDA Nod For Front-Line HER2+ Breast Cancer Maintenance
Fake pharma racket sourced Pfizer labels from Turkiye: SIT | India News
AI Breakthrough: Room Temperature Storage for mRNA Vaccines, ETPharma
Pfizer Job Cuts Italy: Pfizer to Lay Off 330 Workers at Sicily Plant Amid Industry Cuts, ETHRWorld
Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate
Canandaigua National Trust Co of Florida Purchases New Shares in Pfizer Inc. $PFE - Zolmax
Canandaigua National Trust Co of Florida Buys New Position in Pfizer Inc. $PFE
Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?
Pfizer (PFE) Trades Below Its Own Average Multiple, Is It Cheap for a Reason?
Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa | Morningstar
Pfizer (NYSE:PFE) Stock Price Up 1.7% After Dividend Announcement - Stock Observer
Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer | Morningstar
Pfizer (PFE) Posted Positive Phase 3 Vitiligo Results For LITFULO
Pfizer Inc. (NYSE:PFE) Shareholders to Collect $0.43 Quarterly Dividend - Zolmax
Pfizer Inc. (NYSE:PFE) Shareholders Set to Receive $0.43 Quarterly Dividend
Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was "Playing With Fire." Here Are 3 Stocks Still Cheap Enough to Buy. - AOL
Johnson & Johnson $JNJ Stock Holdings Cut by Hall Laurie J Trustee - Markets Daily
Is Pfizer (PFE) a Good or Bad Investment at Today's Price?
5,446 Shares in Johnson & Johnson $JNJ Bought by Eleva Capital SAS - Zolmax
Johnson & Johnson $JNJ Shares Newly Purchased by Eleva Capital SAS
Pfizer Declares $0.43 Fourth-Quarter Dividend For Shareholders
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher
Johnson & Johnson $JNJ Shares Sold by Iowa State Bank - Daily Political
Pfizer (NYSE:PFE) Stock Price Down 1.4% - What's Next?
Top Pharmaceutical Stocks To Follow Now - October 5th - Markets Daily
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
Top Pharmaceutical Stocks To Follow Now - October 5th - Stock Observer
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes
Pfizer (NYSE:PFE) Stock Falls 1.4% - Should You Sell? - Daily Political
Vaxcyte skyrockets on 'near best-case' pneumococcal vaccine data
Pfizer describes new APLNR agonists
Pfizer's Turnaround Could Be Bigger Than Investors Think, Set For 20% Upside
Got $10,000 to Invest in October? These Stocks Could Generate Over $634 in Annual Income.
Best Pharmaceutical Stocks To Add to Your Watchlist - October 4th - Stock Observer
COPD trial wins spur broad respiratory hopes
Pay Me While I Wait: 3 Turnaround Stocks That Keep Paying Investors Through the Rebuild
Here's Exactly Why I'm Not Afraid of Pfizer's 6% Dividend Yield
Reviewing Verastem (NASDAQ:VSTM) and Nektar Therapeutics (NASDAQ:NKTR) - Markets Daily
Pfizer (PFE) and Its Rivals Critical Comparison - Markets Daily
Pharmaceutical Stocks To Watch Now - October 3rd - Zolmax
Pfizer (PFE) Receives a Hold from Leerink Partners
Fake drug probe: Karnataka FDA seeks Pfizer intervention on fake antibiotics
3 AI Healthcare Stocks With Earnings Growth Up To 15%
Pfizer (NYSE:PFE) Shares Down 1.1% - Time to Sell?
Pfizer Sues Sun Pharmaceutical to Block Copies of Cancer Drug
'They knew about myocarditis in kids, yet…': Florida sues Pfizer over 'deceptive COVID Vaccine lies' - The Economic Times Video | ET Now
Novartis taps Abogen's RNA platform in potential $7.8B deal
PFE: Pricing Pressure Still Matters, Pipeline Execution Now Carries The Bear Case
Florida AG sues Pfizer, CEO over COVID-19 vaccine safety claims
Florida Attorney General Files Lawsuit Against Pfizer Over COVID-19 Vaccine Safety Claims, ETPharma
Pfizer (NYSE:PFE) Stock Falls 1.5% - What's Next? - Markets Daily
Pfizer (NYSE:PFE) Stock Falls 1.5% - Time to Sell?
Pfizer-Sankar Foundation eye camp screens 1,113 patients
'Deceptively marketing the products as safe': Pfizer sued for deceiving public about COVID shots
Florida sues Pfizer over Covid-19 vaccine safety claims
Does Pfizer (PFE) Have A New Growth Driver In Tilrekimig?
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment | Morningstar
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
6 High-Yield Stocks Where the Market May Be Warning of a Dividend Cut
Treasury Yields Are Above 5%. These 4 Dividend Stocks Still Make the Cut
Pfizer's Tilrekimig Delivers Significant Skin Clearance In Phase 2 Atopic Dermatitis Study
Pfizer's Tilrekimig Meets Phase 2 Primary Endpoint In Atopic Dermatitis
Lyme Disease Market: Steady Growth Ahead as Vaccine Candidates and Novel Preventive Therapies Advance Through 2034 | ABNewswire
Pfizer CEO Albert Bourla on AI and the future of medicine
Promising Pharmaceutical Stocks Worth Watching - September 30th
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat
Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson
Analyzing Perrigo (NYSE:PRGO) and Pfizer (NYSE:PFE) - Stock Observer
Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer
Vascular Dementia Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 - DelveInsight | Pfizer, Gilead Sciences, ViiV Healthcare | ABNewswire
Carlyle Wins Dispute Over AI Platform Linked to Pfizer Covid Vax
PFIZER News
GE Vernova Stock Forecast & Analysis: Will Data-Centre Power and Grid Investment Fuel the Next Rally?
Samsung Electronics Stock Price Forecast 2026–2027: Can Record Q3 Profit Extend the AI Rally?
GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far
Latest news
Show more
Palantir Stock Hits Record Close as Barclays Sets $265 Price Target
Lumentum Stock Jumps 5.22% as AI Optical Components Sell Out Through Early 2029
US Consumer Sentiment Falls to 46.3 as Inflation Expectations Rise to 4.7%
US CPI Preview: Will September Inflation Revive October Fed Rate-Hike Bets?
Gold Price Forecast Next Week: Can XAU/USD Hold $4,200 Before US CPI?
